{"id":"https://openalex.org/W7225317598","doi":"https://doi.org/10.1136/jitc-2026-sitc2026.0052","title":"52 Immunotoxicity assessment of biotherapeutics using the NAM ID.Flow\u00ae: an ex vivo whole blood assay under continuous flow","display_name":"52 Immunotoxicity assessment of biotherapeutics using the NAM ID.Flow\u00ae: an ex vivo whole blood assay under continuous flow","publication_year":2026,"publication_date":"2026-11-01","ids":{"openalex":"https://openalex.org/W7225317598","doi":"https://doi.org/10.1136/jitc-2026-sitc2026.0052"},"language":"en","primary_location":{"id":"doi:10.1136/jitc-2026-sitc2026.0052","doi":"https://doi.org/10.1136/jitc-2026-sitc2026.0052","is_oa":true,"landing_page_url":"https://doi.org/10.1136/jitc-2026-sitc2026.0052","pdf_url":"https://jitc.bmj.com/content/14/Suppl_2/A57.full.pdf","source":{"id":"https://openalex.org/S2754803477","display_name":"Journal for ImmunoTherapy of Cancer","issn_l":"2051-1426","issn":["2051-1426"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Regular Abstracts","raw_type":"proceedings-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref","doaj"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://jitc.bmj.com/content/14/Suppl_2/A57.full.pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5033150102","display_name":"Erika A.K. Fletcher","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Erika Fletcher","raw_affiliation_strings":["Immuneed AB, Uppsala, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Immuneed AB, Uppsala, UK","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5117232291","display_name":"Helena Harlin Laven","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Helena Harlin Laven","raw_affiliation_strings":["Immuneed AB, Uppsala, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Immuneed AB, Uppsala, UK","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5026234181","display_name":"Elisabet Gullberg","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Elisabet Gullberg","raw_affiliation_strings":["Immuneed AB, Uppsala, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Immuneed AB, Uppsala, UK","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5146841648","display_name":"Louise Nilsson","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Louise Nilsson","raw_affiliation_strings":["Immuneed AB, Uppsala, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Immuneed AB, Uppsala, UK","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5010732001","display_name":"Jessica Norberg","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jessica Norberg","raw_affiliation_strings":["Immuneed AB, Uppsala, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Immuneed AB, Uppsala, UK","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111902778","display_name":"Gunilla T\u00f6rnqvist","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Gunilla T\u00f6rnqvist","raw_affiliation_strings":["Immuneed AB, Uppsala, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Immuneed AB, Uppsala, UK","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5160764413","display_name":"William Copper","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"William Copper","raw_affiliation_strings":["Immuneed AB, Uppsala, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Immuneed AB, Uppsala, UK","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5132858807","display_name":"Alexander Kele","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Alexander Kele","raw_affiliation_strings":["Immuneed AB, Uppsala, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Immuneed AB, Uppsala, UK","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5160532180","display_name":"Sakthi Ponandai Srinivasan","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Sakthi Ponandai Srinivasan","raw_affiliation_strings":["Immuneed AB, Uppsala, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Immuneed AB, Uppsala, UK","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5020151936","display_name":"Sara M. Mangsbo","orcid":"https://orcid.org/0000-0002-1355-2678","observed_orcids":["https://orcid.org/0000-0002-1355-2678"]},"institutions":[{"id":"https://openalex.org/I123387679","display_name":"Uppsala University","ror":"https://ror.org/048a87296","country_code":"SE","type":"education","lineage":["https://openalex.org/I123387679"]}],"countries":["SE"],"is_corresponding":false,"raw_author_name":"Sara Mangsbo","raw_affiliation_strings":["Uppsala University, Uppsala, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Uppsala University, Uppsala, UK","institution_ids":["https://openalex.org/I123387679"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":2490,"currency":"USD","value_usd":2490},"apc_paid":{"value":2490,"currency":"USD","value_usd":2490},"fwci":null,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":"A57","last_page":"A57"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T14072","display_name":"Immunotoxicology and immune responses","score":0.8798999786376953,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T14072","display_name":"Immunotoxicology and immune responses","score":0.8798999786376953,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.08910000324249268,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12281","display_name":"Animal testing and alternatives","score":0.011699999682605267,"subfield":{"id":"https://openalex.org/subfields/3404","display_name":"Small Animals"},"field":{"id":"https://openalex.org/fields/34","display_name":"Veterinary"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/immunotoxicity-assessment","display_name":"immunotoxicity assessment","score":0.9660000205039978},{"id":"https://openalex.org/keywords/biological-therapy","display_name":"biologic therapy","score":0.8339999914169312},{"id":"https://openalex.org/keywords/therapeutic-antibodies","display_name":"therapeutic antibodies","score":0.9290000200271606},{"id":"https://openalex.org/keywords/alemtuzumab","display_name":"alemtuzumab","score":0.9110000133514404},{"id":"https://openalex.org/keywords/cetuximab","display_name":"cetuximab","score":1.0},{"id":"https://openalex.org/keywords/cytokine-production","display_name":"cytokine production","score":0.8080000281333923},{"id":"https://openalex.org/keywords/complement-activation","display_name":"complement activation","score":0.9919999837875366},{"id":"https://openalex.org/keywords/interferon-gamma","display_name":"interferon-gamma","score":0.7799999713897705},{"id":"https://openalex.org/keywords/interleukin-6","display_name":"interleukin-6","score":0.8759999871253967},{"id":"https://openalex.org/keywords/interleukin-8","display_name":"interleukin-8","score":0.7960000038146973},{"id":"https://openalex.org/keywords/tnf-alpha","display_name":"TNF-\u03b1","score":0.9480000138282776},{"id":"https://openalex.org/keywords/preclinical-safety-evaluation","display_name":"preclinical safety","score":0.49000000953674316}],"concepts":[{"id":"https://openalex.org/C26291073","wikidata":"https://www.wikidata.org/wiki/Q310484","display_name":"Ex vivo","level":3,"score":0.8507999777793884},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7878999710083008},{"id":"https://openalex.org/C1621761","wikidata":"https://www.wikidata.org/wiki/Q7997549","display_name":"Whole blood","level":2,"score":0.7742999792098999},{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.6546000242233276},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.5734999775886536},{"id":"https://openalex.org/C2779015954","wikidata":"https://www.wikidata.org/wiki/Q420164","display_name":"Alemtuzumab","level":3,"score":0.5593000054359436},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5408999919891357},{"id":"https://openalex.org/C2778690821","wikidata":"https://www.wikidata.org/wiki/Q212354","display_name":"Cytokine","level":2,"score":0.5371999740600586},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.4781999886035919},{"id":"https://openalex.org/C2780850621","wikidata":"https://www.wikidata.org/wiki/Q3961647","display_name":"Cytokine release syndrome","level":5,"score":0.39730000495910645},{"id":"https://openalex.org/C63363279","wikidata":"https://www.wikidata.org/wiki/Q5133848","display_name":"Clinical significance","level":2,"score":0.3869999945163727},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.36890000104904175},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.3628999888896942},{"id":"https://openalex.org/C111684460","wikidata":"https://www.wikidata.org/wiki/Q334848","display_name":"Complement system","level":3,"score":0.3402000069618225},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.3269999921321869},{"id":"https://openalex.org/C553184892","wikidata":"https://www.wikidata.org/wiki/Q1141429","display_name":"Flow cytometry","level":2,"score":0.326200008392334},{"id":"https://openalex.org/C2780614586","wikidata":"https://www.wikidata.org/wiki/Q6664446","display_name":"Local lymph node assay","level":4,"score":0.3147999942302704},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.3037000000476837},{"id":"https://openalex.org/C33618052","wikidata":"https://www.wikidata.org/wiki/Q6013136","display_name":"In vitro toxicology","level":3,"score":0.30140000581741333},{"id":"https://openalex.org/C2780272996","wikidata":"https://www.wikidata.org/wiki/Q1261151","display_name":"Therapeutic drug monitoring","level":3,"score":0.2865000069141388},{"id":"https://openalex.org/C72563966","wikidata":"https://www.wikidata.org/wiki/Q1303415","display_name":"Cohort","level":2,"score":0.25850000977516174},{"id":"https://openalex.org/C542903549","wikidata":"https://www.wikidata.org/wiki/Q422248","display_name":"Monoclonal antibody","level":3,"score":0.25189998745918274}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.1136/jitc-2026-sitc2026.0052","doi":"https://doi.org/10.1136/jitc-2026-sitc2026.0052","is_oa":true,"landing_page_url":"https://doi.org/10.1136/jitc-2026-sitc2026.0052","pdf_url":"https://jitc.bmj.com/content/14/Suppl_2/A57.full.pdf","source":{"id":"https://openalex.org/S2754803477","display_name":"Journal for ImmunoTherapy of Cancer","issn_l":"2051-1426","issn":["2051-1426"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Regular Abstracts","raw_type":"proceedings-article"},{"id":"pmh:oai:doaj.org/article:cfe7661175534404a861b435316b5a39","doi":null,"is_oa":false,"landing_page_url":"https://doaj.org/article/cfe7661175534404a861b435316b5a39","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Journal for ImmunoTherapy of Cancer, Vol 14, Iss Suppl 2 (2026)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.1136/jitc-2026-sitc2026.0052","doi":"https://doi.org/10.1136/jitc-2026-sitc2026.0052","is_oa":true,"landing_page_url":"https://doi.org/10.1136/jitc-2026-sitc2026.0052","pdf_url":"https://jitc.bmj.com/content/14/Suppl_2/A57.full.pdf","source":{"id":"https://openalex.org/S2754803477","display_name":"Journal for ImmunoTherapy of Cancer","issn_l":"2051-1426","issn":["2051-1426"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Regular Abstracts","raw_type":"proceedings-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9537000060081482,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W7225317598.pdf","grobid_xml":"https://content.openalex.org/works/W7225317598.grobid-xml"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4409417314","https://openalex.org/W2412991733","https://openalex.org/W3112023905","https://openalex.org/W4409633252","https://openalex.org/W4414073835","https://openalex.org/W2167569363","https://openalex.org/W2070976367","https://openalex.org/W7148852593","https://openalex.org/W7135298189","https://openalex.org/W2060543258"],"abstract_inverted_index":{"Background":[0,229],"Assessing":[1],"the":[2,20,27,39,48,80,121,133,186,220,261,308,318],"immunotoxicity":[3,134],"of":[4,31,41,84,114,135,188,207,283],"advanced":[5],"biotherapeutics":[6,284],"and":[7,15,72,82,95,143,166,192,209,214,230,249,298,326,335],"translational":[8],"data":[9,331],"currently":[10],"available":[11],"from":[12,103],"in":[13,16,62,128,139,152,159,173,254,290],"vitro":[14,291],"vivo":[17,56],"Methods":[18],"to":[19,37,78,92,120,148,182,195,219,272,276,307,320],"clinic":[21],"can":[22,269],"be":[23,270],"challenging.":[24],"In":[25,64,200,233,256],"particular,":[26],"limited":[28],"physiological":[29],"relevance":[30,81],"many":[32],"models":[33],"makes":[34,313],"it":[35,125],"difficult":[36],"assess":[38],"risks":[40],"tested":[42],"drug":[43],"candidates.":[44],"Here,":[45],"we":[46,67,237,258],"used":[47,151,271],"Novel":[49],"approach":[50],"methodology":[51],"(NAM),":[52],"ID.Flow\u00ae,":[53,201],"an":[54,107],"ex":[55],"test":[57,87,146],"system":[58,123,147,315],"mimicking":[59],"human":[60,329],"blood":[61,100,117,223],"circulation.Methods":[63],"this":[65,314],"study,":[66],"selected":[68],"two":[69],"antibodies":[70,138,216],"(alemtuzumab":[71],"cetuximab)":[73],"for":[74,161,332],"further":[75],"investigation,":[76],"aiming":[77],"identify":[79],"sensitivity":[83,287],"our":[85,145],"NAM":[86,262],"system,":[88,109],"ID.Flow\u00ae":[89,225,263,306],"with":[90,110,285],"regard":[91],"cytokine":[93,157],"release":[94,158,211],"complement":[96],"activation.":[97],"Fresh":[98],"whole":[99,222],"was":[101,118,126,203],"collected":[102],"healthy":[104],"volunteers":[105],"using":[106],"open":[108],"a":[111,140,204,265,301],"minimal":[112],"addition":[113],"anti-coagulant.":[115],"The":[116],"transferred":[119],"ID.Flow":[122],"where":[124],"kept":[127],"constant":[129],"circulation.":[130],"We":[131,155],"assessed":[132],"these":[136,234],"therapeutic":[137],"larger":[141],"cohort":[142],"compared":[144,194,218],"other":[149],"commonly":[150],"vitro-based":[153],"assays.Results":[154],"measured":[156],"plasma":[160],"IFN-\u03b3,":[162,189],"IL-2,":[163],"IL-6,":[164,190],"IL-8,":[165,191],"TNF-\u03b1.":[167],"After":[168],"4":[169],"hours,":[170],"no":[171],"differences":[172],"cytokines":[174],"were":[175],"seen":[176],"when":[177,217],"comparing":[178],"vehicle":[179],"control":[180],"(PBS)":[181],"cetuximab.":[183],"Alemtuzumab":[184],"increased":[185],"levels":[187],"TNF-\u03b1":[193],"PBS,":[196],"confirming":[197],"clinical":[198,310],"data.":[199],"there":[202],"greater":[205],"separation":[206],"IFN-\u03b3":[208],"IL-8":[210],"between":[212],"low-":[213],"high-risk":[215],"plate-based":[221],"assays.":[224],"also":[226],"exhibited":[227,300],"less":[228,231],"variability.":[232],"same":[235],"runs":[236],"saw":[238],"that":[239,260,268],"alemtuzumab":[240,297],"but":[241],"not":[242],"cetuximab":[243,299],"induced":[244],"C3a":[245],"(2.1-fold":[246],"vs.":[247,252],"PBS)":[248,253],"C5a":[250],"(2.5-fold":[251],"ID.Flow\u00ae.Conclusions":[255],"conclusion,":[257],"show":[259],"is":[264,317],"sensitive":[266],"assay":[267],"detect":[273],"even":[274],"low":[275],"moderate":[277],"clinically":[278],"relevant":[279],"unwanted":[280],"immunotoxic":[281],"responses":[282],"higher":[286],"over":[288],"conventional":[289],"models.":[292],"Therapeutic":[293],"antibodies,":[294],"such":[295],"as":[296],"similar":[302],"toxicity":[303],"profile":[304],"within":[305],"observed":[309],"findings.":[311],"What":[312],"unique":[316],"ability":[319],"simultaneously":[321],"measure":[322],"multiple":[323],"immune-toxicological":[324],"readouts":[325],"provide":[327],"comprehensive":[328],"specific":[330],"candidate":[333],"selection":[334,337],"dose":[336],"before":[338],"IND.":[339]},"counts_by_year":[],"updated_date":"2026-11-08T12:12:28.789561","created_date":"2026-11-06T00:00:00"}